Medicine journal updates
-
Upload
rajsantan -
Category
Health & Medicine
-
view
21 -
download
0
Transcript of Medicine journal updates
Dr. Raj santan. k Prof. Dr. G. Vasumathi unit
stanley medical college
Medicine Journal updates
clindamycin versus trimethoprim- sulfamethoxazole for uncomplicated skin infections
There was no significant difference between clindamycin and tmp-smx with respect to either efficacy or side effect profile in both children and adults.
NEJM-MARCH,19,2015
Efficacy and safety of canagliflozin when used in conjunction with insulin therapy in type 2 DM
Canagliflozin when added to insulin therapy improved glycemic control and decreased body weight
S.E: genital mycotic infections, uti diabetes care , 2015
BLOOD PRESSURE SHOULD BE MEASURED IN BOTH ARMS
DIFFERENCE >10 mmhg IN INTER ARM BLOOD PRESSURE LINKED TO GREATER RISK OF FUTURE CARDIOVASCULAR EVENTS.
AMERICAN JOURNAL OF MEDICINE,MARCH
SPUTUM BACTERIOLOGY AND ANTI BIOTIC SENSITIVITY PATTERN OF PATIENTS HAVING ACUTE EXACERBATION OF COPD IN INDIA
Streptococcus pneumoniae is the most common pathogen in patients with AECOPD.
Piperacillin +Tazobactum should be the first choice empirical antibiotic.
Quinolones are less effective journal of pulmonary and respiratory medicine, january
26,2015
EFFICACY OF PIRFENIDONE FOR IDIOPATHIC PULMONARY FIBROSIS
Pirfenidone reduces the rate of annual FVC decline in patients with IPF.
Pirfenidone has well-established anti fibrotic and anti inflammatory properties
downregulates the production of growth factors and procollagens I and II.
LOW RISK DIET AND LIFE STYLE HABITS IN THE PRIMARY PREVENTION OF MI IN MEN
Almost 4 out of 5 MI in men may be preventable with a combined low risk behaviour.
JACC,FEBRUARY,17,2015.
Low risk behaviour :
1.Healthy diet2.Moderate alcohol consumption
10-30g/day3.No smoking4.Being physically active,walking
/bicycling>=40mins/day and exercising>=1 hour/week
5.No abdominal adiposity(waist circumference <95 cm.)
IVABRADINE
Approved for treatment of chronic heart failure.
Indicated to reduce the risk of hospitalization for worsening heart failure in patients with :
Stable , symptomatic chronic heart failure with lvef <=35%, who are in sinus rhythm with resting heart rate >=70 beats / minute and either on maximal tolerated dose of beta blockers or in whom beta blocker is contrindicated
FDA approval, APRIL,2015.
M.0.A OF IVABRADINE
Inhibits if channels
Recommended dosage: 5 mg b.d 2
weeks
7.5 mg b.d
MONGERSEN:AN ORAL SMAD -7 ANTI SENSE OLIGONUCLEOTIDE AND CROHNS DISEASE
Crohns disease
High levels of SMAD 7
Reduced levels of TGF –BETA ( immuno suppressive cytokine)
NEJM-MARCH,19,2015
Prednisolone or pentoxyfylline for alcoholic hepatitis
Pentoxyfylline did not improve survival in patients with alcoholic hepatitis
Prednisolone was associated with a reduction in 28 day mortality that did not reach significance and no improvement in outcomes at 90 days or 1 year
NEJM, APRIL 23, 2015
The Path to an Angiotensin Receptor Antagonist-Neprilysin Inhibitor in the Treatment of Heart Failure
This new molecule is named LCZ-696,is a combination of ARB and neprilysin inhibitor
Neprilysin is a zinc-dependent metalloprotease that cleaves peptides at the amino side of hydrophobic residues and inactivates several peptide hormones
JACC MARCH 2015
Thank you